The Dilution Paradox in Extracellular Vesicle Flow Cytometry
Journal of Extracellular Vesicles · 2026
DOI: 10.1002/jev2.70312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Joyce Rops und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Laboratory of Experimental Clinical Chemistry, Amsterdam UMC, Unive…. Hauptthemen laut MEDLINE: Flow Cytometry, Extracellular Vesicles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Heart Foundation, Dutch Research Council, Hartstichting.
Abstract (Originalsprache)
Concentrations of extracellular vesicles (EVs) can be measured by flow cytometry, which detects fluorescence and light scattering signals from single particles. To ensure single particle detection, plasma samples are diluted based on their particle concentration, which can differ 100‐fold between samples. Here we studied how sample dilution affects EV detection by flow cytometry. EVs were measured in human plasma (i) with different concentrations of spiked‐in purified lipoproteins, (ii) at different dilutions, and (iii) using either scatter‐triggering or fluorescence‐triggering. In addition, the reliability of two published clinical EV studies was evaluated using an analytical model. Our results show that the minimum dilution factor to prevent swarm detection by the light scattering detector can exceed the maximum dilution factor that ensures labelled EVs outnumber fluorescent background events. This ‘dilution paradox’ precludes reliable detection of both fluorescence and light scattering signals of EVs for some samples. In the two clinical studies, 30% and 65% of the measurements were unreliable, depending on the label used. Therefore, results from previous studies should be re‐evaluated. The dilution paradox might be overcome by using fluorescence‐triggering at a fixed sample dilution, removing non‐EV particles from the sample, removing fluorescent particulates from staining reagents, and setting stricter inclusion criteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Laboratory of Experimental Clinical Chemistry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Biomedical Engineering & Physics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Atherosclerosis and Ischemic Syndromes, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
- 1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Joyce Rops, Naomi Buntsma, Aleksandra Gąsecka, Leonie de Rond, Anne Yaël Nossent, Nyika D Kruyt, Rienk Nieuwland, Edwin van der Pol
Förderung
- Dutch Heart Foundation
- Dutch Research Council
- Hartstichting
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Rops, J., Buntsma, N., Gąsecka, A., de Rond, L., Nossent, A. Y., Kruyt, N. D., Nieuwland, R., & van der Pol, E. (2026). The Dilution Paradox in Extracellular Vesicle Flow Cytometry. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70312
Vancouver
Rops J, Buntsma N, Gąsecka A, de Rond L, Nossent AY, Kruyt ND, et al. The Dilution Paradox in Extracellular Vesicle Flow Cytometry. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70312
BibTeX
@article{Rops2026,
author = {Rops, Joyce and Buntsma, Naomi and Gąsecka, Aleksandra and de Rond, Leonie and Nossent, Anne Yaël and Kruyt, Nyika D and Nieuwland, Rienk and van der Pol, Edwin},
title = {The Dilution Paradox in Extracellular Vesicle Flow Cytometry},
journal = {Journal of Extracellular Vesicles},
year = {2026},
doi = {10.1002/jev2.70312}
}
EUVIMED